Two other comparative studies have indicated that low expression and absence of BMP2 might be related to progression to a more aggressive phenotype in PCa [53] and signal poor prognosis of patients with ovarian cancer [54]. This evidence concerns the gene BMP2 and ovarian carcinoma.